Olatec Therapeutics, Inc. ("Olatec"), a clinical stage biotechnology company leading the development of specific NLRP3 inhibitors, presented preclinical data at The Michael J. Fox Foundation (MJFF) ...
BioAge Labs is rated 'Hold' after a rally driven by BGE-102 Phase 1 data and Eli Lilly's Ventyx acquisition. Click to read my ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback